Celcuity appoints ex-Incyte CFO David Gryska to board

By Public Technologies
  • Celcuity appointed David W. Gryska to its board as it shifts to a commercial-stage business following its first FDA approval.
  • Gryska previously served as executive vice president and CFO at Incyte, with earlier CFO roles at Celgene and Scios.
  • He has held board seats across public biotech companies, including a more than 15-year tenure on Seagen’s board.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020800PRIMZONEFULLFEED9838354) on October 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk